NCT07085819招募中不适用
A Prospective, Randomized, Double Blind, Placebo Controlled Study To Evaluate The Effects Of Ashwagandha (Withania Somnifera,Ws) Root Plus Leaf Aqueous Extract On Quality Of Sleep In Subjects With Non-Restorative
Kerry Group P.L.C2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2025年7月15日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 160
- 试验地点
- 2
- 主要终点
- Sleep restorative quality
研究概览
简要总结
The goal of this clinical trial is to evaluate the effect of the Botanical Extract in improving sleep symptoms of nonrestorative sleep (NRS) in healthy adults. The main question it aims to answer is
• Does the Botanical Extract improve sleep quality and reduce symptoms of nonrestorative sleep (NRS)? Researchers will compare the Botanical Extract to a placebo to see if it works.
Participants will:
- Take one of 3 doses of the Botanical Extract (125 mg/day, 250mg/day ,500mg/day) or a placebo every day for 8 weeks.
- Visit the clinic four times for checkups and tests and receive three follow-up phone calls.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Be able to give written informed consent.
- •Be between 18 and 65 years, inclusive.
- •Self-reported unrefreshing sleep despite sufficient sleep duration for at least three nights a week over a one-month period.
- •Have a RSQ-W total score of ≤50 at screening.
- •TSH values between 0.27 - 4.20 miU/L
- •Is in general good health, as determined by the investigator.
- •Willing to consume the Study Product daily for the duration of the study.
排除标准
- •Participants who are pregnant or wish to become pregnant during the study or who are lactating and/or currently breastfeeding.
- •Participants currently of biological childbearing potential, but not using a continuous effective method of contraception, as outlined below:
- •Complete abstinence from intercourse two weeks prior to administration of the Study Product, throughout the clinical study, until the completion of follow-up procedures or for two weeks following discontinuation of the Study Product in cases where Participant discontinues the study prematurely. (Participants utilizing this method must agree to use an alternate method of contraception if they should become sexually active and will be queried on whether they have been abstinent in the preceding two weeks when they present to the clinic for the final visit).
- •Has a male sexual partner who is surgically sterilized prior to the Screening Visit and is the only male sexual partner for that Participant.
- •Sexual partner(s) is/are exclusively female.
- •Use of acceptable method of contraception, such as a spermicide, mechanical barrier (e.g., male condom, female diaphragm), tubal ligation, or contraceptive pill. The Participant must be using this method for at least one week prior to and one week following the end of the study.
- •Use of any intrauterine device (IUD) or contraceptive implant. The Participant must have the device inserted at least two weeks prior to the first screening visit, throughout the study, and two weeks following the end of the study.
- •Has a score ≥10 on Patient Health Questionnaire 8 item (PHQ-8)
- •Has a score ≥10 on Athens Insomnia Scale (AIS)
- •Participants at a high risk of sleep apnoea as determined by Berlin questionnaire/Score >5 for sleep apnoea.
- •High caffeine intake, >400mg/day
- •Has a history of drug and/or alcohol abuse at the time of enrolment.
- •Has food allergies or other issues with foods that would preclude intake of the Study Products.
- •Is an active smoker or user of nicotine products, or with a history of cigarettes smoking, tobacco or nicotine product use in the last 6 months.
- •Has undertaken shift work within the last three months or plans to undertake shift work during the study.
- •Travel across three time zones in the two months prior to screening or plans to travel across time zones during intervention.
- •Has any significant acute or chronic coexisting health conditions that would prevent them from fulfilling the study requirements, put the Participant at risk or would confound the interpretation of the study results as judged by the investigator on the basis of medical history and routine laboratory test results. Excluded health conditions include:
- •Diagnosed gastrointestinal disease.
- •Respiratory disorders
- •Seizure disorders
- •Type 1 or 2 diabetes mellitus
- •Thyroid disorders
- •Uncontrolled hypertension
- •Cardiovascular disease
- •Immunocompromised health conditions
- •Current or recent (in the 12 weeks prior to screening) use of a medication that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results. Prohibited medications include:
- •Barbiturates, anticonvulsants, benzodiazepines, neuroleptics
- •Current or recent (in the 4 weeks prior to screening) use of prohibited nutritional or non-nutritional supplements, including:
- •Herbal sleep aid supplements (St. John's Wort, Ginkgo-biloba, kava kava)
- •Ashwagandha
- •Caffeine supplements
- •Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the study.
- •Participants may not be participating in other clinical studies. If the participant has previously taken part in an experimental study, the Investigator must ensure sufficient time has elapsed before entry to this study to ensure the integrity of the results.
结局指标
主要结局
Sleep restorative quality
时间窗: 8 weeks
To evaluate the impact of 8 weeks daily supplementation of the Botanical Extract on Non-Restorative Sleep (NRS) as assessed by Restorative Sleep Questionnaire (RSQ-W) score compared to placebo. The total score range from 0-100 with higher scores indicating better restorative sleep.
次要结局
- Sleep Quality(8 weeks)
- Attention-Rapid Visual Information Processing (RVIP)(8 weeks)
- Attention-Sustained Attention to Response Task (SART).(8 weeks)
- Cognition(8 weeks)
- Stress(8 weeks)
- Sleep parameters-Total Sleep Time (TST)(24-hour wear time for 8 weeks)
- Sleep Parameters- Wake After Sleep Onset (WASO)(24-hour wear time for 8 weeks)
- Sleep Parameters- Sleep Onset Latency (SOL)(24-hour wear time for 8 weeks.)
- Sleep Parameters- Sleep Efficiency (SE)(24-hour wear time for 8 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Efficacy test of plant extract on sleepHealthy adultsJPRN-UMIN000048600WELLPHARMA Inc.20
已完成
不适用
The effects of a plant extract B on sleep.o(healthy adults)JPRN-UMIN000035693ION Corporation56
尚未招募
不适用
Efficacy test of plant extract on sleepJPRN-UMIN000047139niversity of Tsukuba90
已完成
不适用
Efficacy of herbal medication in case of sleep disturbances after surgeryF51Nonorganic sleep disordersDRKS00027903ni-Zentrum Naturheilkunde Universitätsklinikum Freiburg22,824
尚未招募
不适用
Trial of the efficacy of food ingredients on sleep quality in healthy men and women (SWE-2019-10)JPRN-UMIN000039553SUNTORY WELLNESS LIMITED90